CG
PGNX

Clinton Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Clinton Group’s Portfolio PGNX Stock Details PGNX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-14,996
Closed -$121K – 428
2018
Q2 		$121K Buy
+14,996
New +$121K 0.02% 336